455 related articles for article (PubMed ID: 28797714)
1. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.
Shrestha E; White JR; Yu SH; Kulac I; Ertunc O; De Marzo AM; Yegnasubramanian S; Mangold LA; Partin AW; Sfanos KS
J Urol; 2018 Jan; 199(1):161-171. PubMed ID: 28797714
[TBL] [Abstract][Full Text] [Related]
2. A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis.
Alanee S; El-Zawahry A; Dynda D; Dabaja A; McVary K; Karr M; Braundmeier-Fleming A
Prostate; 2019 Jan; 79(1):81-87. PubMed ID: 30117171
[TBL] [Abstract][Full Text] [Related]
3. Prospective examination of the changes in the urinary microbiome induced by transrectal biopsy of the prostate using 16S rRNA gene analysis.
Alanee S; El-Zawahry A; Dynda D; McVary K; Karr M; Braundmeier-Fleming A
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):446-452. PubMed ID: 30664733
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Study of the Urinary and Gastrointestinal Microbiome in Prepubertal Males.
Kassiri B; Shrestha E; Kasprenski M; Antonescu C; Florea LD; Sfanos KS; Wang MH
Urology; 2019 Sep; 131():204-210. PubMed ID: 31195012
[TBL] [Abstract][Full Text] [Related]
5. The Microbiome and Genitourinary Cancer: A Collaborative Review.
Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
[TBL] [Abstract][Full Text] [Related]
6. The microbiome in prostate inflammation and prostate cancer.
Porter CM; Shrestha E; Peiffer LB; Sfanos KS
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):345-354. PubMed ID: 29795140
[TBL] [Abstract][Full Text] [Related]
7. Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
Wu P; Zhang G; Zhao J; Chen J; Chen Y; Huang W; Zhong J; Zeng J
Front Cell Infect Microbiol; 2018; 8():167. PubMed ID: 29904624
[TBL] [Abstract][Full Text] [Related]
8. Incontinence medication response relates to the female urinary microbiota.
Thomas-White KJ; Hilt EE; Fok C; Pearce MM; Mueller ER; Kliethermes S; Jacobs K; Zilliox MJ; Brincat C; Price TK; Kuffel G; Schreckenberger P; Gai X; Brubaker L; Wolfe AJ
Int Urogynecol J; 2016 May; 27(5):723-33. PubMed ID: 26423260
[TBL] [Abstract][Full Text] [Related]
9. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms.
Sfanos KS; Sauvageot J; Fedor HL; Dick JD; De Marzo AM; Isaacs WB
Prostate; 2008 Feb; 68(3):306-20. PubMed ID: 18163428
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer.
Guest C; Harris R; Sfanos KS; Shrestha E; Partin AW; Trock B; Mangold L; Bader R; Kozak A; Mclean S; Simons J; Soule H; Johnson T; Lee WY; Gao Q; Aziz S; Stathatou PM; Thaler S; Foster S; Mershin A
PLoS One; 2021; 16(2):e0245530. PubMed ID: 33596212
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: Microbiome - the 'unforeseen organ'.
Manzoor MAP; Rekha PD
Nat Rev Urol; 2017 Sep; 14(9):521-522. PubMed ID: 28654089
[No Abstract] [Full Text] [Related]
12. Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer.
Fujita K; Hayashi T; Matsuzaki K; Nakata W; Masuda M; Kawashima A; Ujike T; Nagahara A; Tsuchiya M; Kobayashi Y; Nojima S; Uemura M; Morii E; Miyoshi E; Nonomura N
Oncotarget; 2016 Aug; 7(35):56643-56649. PubMed ID: 27494861
[TBL] [Abstract][Full Text] [Related]
13. The Microbiome and Prostate Cancer Risk.
Wheeler KM; Liss MA
Curr Urol Rep; 2019 Sep; 20(10):66. PubMed ID: 31493090
[TBL] [Abstract][Full Text] [Related]
14. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
McKiernan J; Donovan MJ; O'Neill V; Bentink S; Noerholm M; Belzer S; Skog J; Kattan MW; Partin A; Andriole G; Brown G; Wei JT; Thompson IM; Carroll P
JAMA Oncol; 2016 Jul; 2(7):882-9. PubMed ID: 27032035
[TBL] [Abstract][Full Text] [Related]
15. Urinary Microbiome and Psychological Factors in Women with Overactive Bladder.
Wu P; Chen Y; Zhao J; Zhang G; Chen J; Wang J; Zhang H
Front Cell Infect Microbiol; 2017; 7():488. PubMed ID: 29230385
[No Abstract] [Full Text] [Related]
16. The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women.
Govender Y; Gabriel I; Minassian V; Fichorova R
Front Cell Infect Microbiol; 2019; 9():133. PubMed ID: 31119104
[TBL] [Abstract][Full Text] [Related]
17. The human urinary microbiome and how it relates to urogynecology.
Schneeweiss J; Koch M; Umek W
Int Urogynecol J; 2016 Sep; 27(9):1307-12. PubMed ID: 26811114
[TBL] [Abstract][Full Text] [Related]
18. Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer.
Pannek J; Rittenhouse HG; Evans CL; Finlay JA; Bruzek DJ; Cox JL; Chan DW; Subong EN; Partin AW
Urology; 1997 Nov; 50(5):715-21. PubMed ID: 9372881
[TBL] [Abstract][Full Text] [Related]
19. The Urinary Tract Microbiome in Health and Disease.
Aragón IM; Herrera-Imbroda B; Queipo-Ortuño MI; Castillo E; Del Moral JS; Gómez-Millán J; Yucel G; Lara MF
Eur Urol Focus; 2018 Jan; 4(1):128-138. PubMed ID: 28753805
[TBL] [Abstract][Full Text] [Related]
20. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study.
Gittelman MC; Hertzman B; Bailen J; Williams T; Koziol I; Henderson RJ; Efros M; Bidair M; Ward JF
J Urol; 2013 Jul; 190(1):64-9. PubMed ID: 23416644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
